With the EU Regulation 2025/1466 Key requirements for the Pharmacovigilance (PV) Noticeably, the focus is shifting away from pure formalism towards Traceability, process quality and transparent documentation. For pharmaceutical companies, this means specifically: PV processes must not only function, but proven, versioned and auditable be, and that is along the entire process chain from detection to action.
This increases expectations for the organization, IT systems, and governance alike. In particular, the following are required:
- Complete documentation of PV-relevant content and decisions
- Risk-based assessment of deviations and process risks
- Rapid response to potentially critical messages
- international data standards and consistent chains of evidence
- Audit and inspection capability for internal and regulatory audits
evalii® It provides the technological and procedural foundation for this. The platform supports companies not only in meeting regulatory requirements, but also in... to actively control.
evalii® is a structured system for monitoring, evaluation and Documentation of potentially pharmacovigilance-relevant content, especially from digital channels. This is precisely where a practical problem often lies: While companies can often monitor social media, contact forms, or platform comments, the regulatory-required documentation is often manual, fragmented, and not consistently audit-proof.
evalii® provides a solution here by handling all process steps standardized and understandable be depicted.
The platform helps answer key audit questions such as:
- Which message was detected and when?
- How was it evaluated, classified, and prioritized?
- To whom was it forwarded and when?
- Who was involved and what measures were taken?
This creates a transparent, audit-proof workflow, which can be adapted to existing role models and SOPs.
The new EU regulation reinforces the requirement that PV processes not only be "lived" but also formally verifiable must be. In practice, this means that companies need documented proof that...,
- that PV-relevant content identified become,
- like her rated become,
- how decisions are made,
- and which Measures were hit.
With evalii®, this documentation no longer becomes a manual effort.
This particularly supports:
Compliance with new PSMF (Pharmacovigilance System Master File) requirements
The demands placed on the PV system and its documentation are increasing. evalii® enables the consistent mapping of process logic, responsibilities, and decision-making paths – an essential foundation for auditable PV documentation.
Risk-based assessment of process deviations
Instead of blanket formalism, risk-based analysis takes center stage: Which deviations are critical? Which are tolerable? What measures are required? evalii® provides structured data foundations for this.
Audits require a complete and transparent justification of decisions and responsibilities. evalii® provides a comprehensive history for this purpose: Who assessed what, when, and why? This reduces audit effort and provides security when dealing with regulatory inquiries.
Digital channels are now a key risk factor and, at the same time, a crucial information space. Continuous monitoring is therefore not only an organizational obligation but increasingly a governance requirement: companies must ensure that relevant content is identified and assessed before it gives rise to regulatory or liability risks.
evalii® offers not only safety, but a genuine Early warning function:
- Potentially critical content is identified.
- prioritized and classified
- assigned to the relevant authorities
- and documented along the process chain
This creates responsiveness – and at the same time the required verifiability.
Conclusion:
The new EU regulation requires transparency, reaction speed and documented quality. Companies are therefore faced with the task of not only making PV processes more efficient, but above all Auditable and revision-proof to build.
evalii® offers a solution that meets regulatory requirements structured representation, Effort reduced and supports companies in implementing modern PV standards.
With evalii®, the switch to... modern pharmacovigilance.
English 
German